Zixuan Liu

发表

Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors

Yuxian He, Yuanmei Zhu, Hui-hui Chong, 2019, Viruses.

A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity

C. Qin, Yusen Zhou, Yuxian He, 2017, Journal of Virology.

Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study

Changhui Wang, S. Xie, Zixuan Liu, 2022, Frontiers in Oncology.

Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial–approved membrane fusion inhibitor

Yuxian He, Xiaohui Ding, Yuanmei Zhu, 2018, The Journal of Biological Chemistry.

Expression, purification and biological effect of a novel single chain Fv antibody and protamine fusion protein for the targeted delivery of siRNAs to FGFR3 positive cancer cells

Xinxin Wang, Yechen Xiao, C. Zang, 2017 .

Expression and purification of soluble single-chain Fv against human fibroblast growth factor receptor 3 fused with Sumo tag in Escherichia coli

Xiaokun Li, H. Fan, Xinxin Wang, 2015 .

Mechanism of HIV-1 Resistance to an Electronically Constrained α-Helical Peptide Membrane Fusion Inhibitor

Yuxian He, Xiaohui Ding, Yuanmei Zhu, 2018, Journal of Virology.

New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis

Chunxiang Luo, Yu Liu, Xueyan Liang, 2022, Computational and mathematical methods in medicine.

High-level expression, purification, and characterization of bifunctional ScFv-9R fusion protein

Xiaokun Li, Xiguang Zhang, Yan Sun, 2014, Applied Microbiology and Biotechnology.

High-level expression, purification, and characterization of bifunctional ScFv-9R fusion protein

Xiaokun Li, Xiguang Zhang, Yan Sun, 2014, Applied Microbiology and Biotechnology.